|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 他汀类药物降低低密度脂蛋白胆固醇的长期安全性和有效性:苏格兰西部地区冠状动脉性心脏病预防20年随访研究显示文摘以他汀类药物为基础降低低密度脂蛋白胆固醇(low density lipoprotein cholesterol,LDL-C)的临床试验随访时间的延长加深了对他汀类药物的安全性和有效性的认知。该研究评估长期使用他汀类药物治疗对一个高危男性队列死亡率和累积死亡率的影响。方法和结果:苏格兰西部地区冠状动脉性心脏病(冠心病)预防研究是一项针对45~64岁男性高LDL-C血症患者的干预试验,纳入6595例研究对象,随机接受普伐他汀40mg/d或安慰剂,平均治疗4.9年,随后根据电子健康档案中的资料分析此后20年主要健康事件的发生。他汀类药物的使用被记录至试验后5年。 | 刘莉 叶鹏 Ford I Murray H McCowan C Packard CJ | 2016 | 中华高血压杂志2016，24，2： | 3 |
| 2 | Influence of moisture, temperature, and substrate on snapping turtle eggs and embryos 显示文摘 | Packard G C Packard M J Miller K | 1987 | Ecology1987，68，4： | 1 |
| 3 | Overproduc-tion of large VLDL particles is driven by increased liver fat content in man显示文摘 | Adiels M Taskinen MR Packard C | 2006 | Diabetologia2006，49，4： | 1 |
| 4 | Water relations of chelonian eggs and embryos : is wetter better 显示文摘 | Packard G C | 1999 | Am Zool1999，39，： | 1 |
| 5 | Restriction Fragment Length Polymorphisms in the Apo B Gene in Relation to Coronary Heart Disease in a Southern Asian Population显示文摘 | MENDIS S SHEPHERD J PACKARD C J | 1991 | Chin Chim Acta1991，196，： | 1 |
| 6 | Potential pathogenic roles of aberrant lipoprotein and fatty acid metabolism in preeclampsia显示文摘 | SATTAR N GAW A PACKARD C J | 1996 | Br J Obstet Gynaecol1996，103，7： | 1 |
| 7 | Lipoprotein-associated phospholipase A2 as an inde- pendent predictor of coronary heart disease 显示文摘 | PACKARD C J O'REILLY D S J CASLAKE M J | 2000 | New England Journal of Medicine2000，343，16： | 1 |
| 8 | Lipoprotein associated phospholipaseA2, platelettactivating factor acetylhydrolase: a po-tential new risk factor for coronary artery disease显示文摘 | Caslake M J Packard C J Sucking KE | 2000 | Atherosclero- sis2000，150，2： | 1 |
| 9 | Improving outcomes through statin therapy- a review of ongoing trials 显示文摘 | Packard C | 2004 | Eur Heart J2004，6，： | 1 |
| 10 | The influence of substrate water potential during incubation on the metabolism of embryonic snapping turtles (Chelydra serpentina) 显示文摘 | Miller K Packard G C | 1992 | Physiological Zoology1992，65，： | 1 |
| 11 | Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease West of Scotland Coronary Prevention Study Group显示文摘 | PACKARD C J O′REILLY D S CASLAKE M J | 2000 | N Engl J Med2000，343，16： | 1 |
| 12 | Effects ofnicotinic acid therapy on plasma high density lipoprotein subfrac-tion distribution and composition and on apolipoprotein A metabo-lism显示文摘 | SHEPHERD J PACKARD C J PATSCH J R | 1979 | Clin Invest1979，63，5： | 1 |
| 13 | Plasm Leptin and the risk of cardiovascular disease in West of Scotland Coronary Prevention Study(WOSCOPS)显示文摘 | Wallace A M MCMahon A D Packard C J | 2001 | Circulation2001，104，： | 1 |
| 14 | Plasma lipoproteins and apolipoproteins as predictor- sol cardiovascular risk and treatment benefit in the prospective study of pravastatin in the elderly at risk 显示文摘 | PACKARD C J FORD I ROBERTSON M | 2005 | Circulation2005，11，： | 1 |
| 15 | Lipoprotein-associated phospholipase A2 (platelet-activating factor acetylhydrolase) and cardiovascular disease显示文摘 | Caslake M J Packard C J | 2003 | Curr Opin Lipidol2003，14，： | 1 |
| 16 | Lipoprotein-associat- ed phospholipase A2, platelet-activating factor acetylhydrolase: a potential new risk factor for coronary artery disease显示文摘 | Caslake MJ Packard C J Suckling KE | 2000 | Atheroscle- rosis2000，150，： | 1 |
| 17 | Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study ( WOSCOPS ) 显示文摘 | Wallace AM McMahon AD Packard C J | 2001 | Circulation2001，104，25： | 1 |
| 18 | Lipoprotein-associated phospholipase A2, plateletactivating factor acetylhydrolase : a potential new risk factor for coronary artery disease显示文摘 | Caslake M J Packard C J Suckling KE | 2000 | Atherosclerosis2000，150，： | 1 |
| 19 | Plasma lipoproteins and apolipoproteins as predictors of cardiovascular risk and treatment benefit in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER)显示文摘 | Packard C J Ford I Robertson M Shepherd J Blauw G J Murphy M B | 2005 | Circulation2005，112，： | 1 |
| 20 | Lipoprorein-associated phospholipase A2 platelet-activating factor acetylhydrolase: a potential new risk factor for coronary artery disease 显示文摘 | Caslake M J Packard C J Suckling KE | 2000 | Atherosclerosis2000，150，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员